UnitedHealthcare to Cover Exome, Genome Sequencing for Certain Non-Cancer Indications

UnitedHealthcare has issued a new policy providing coverage of whole-exome and whole-genome sequencing for a variety of non-cancer indications.

The medical policy, effective April 1, applies to all UHC commercial benefit plans as well as the company’s individual exchange benefit plans in all states except for Colorado, Massachusetts, Nevada, and New York. UHC stated that the policy is limited to genetic testing in an outpatient setting or upon discharge from an inpatient setting.

Source: https://www.genomeweb.com/molecular-diagnostics/unitedhealthcare-cover-exome-genome-sequencing-certain-non-cancer-indications#.ZCs2nHbMKUk